SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-22-007475
Filing Date
2022-07-06
Accepted
2022-07-06 06:04:14
Documents
16
Period of Report
2022-06-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT admp-8k_063022.htm   iXBRL 8-K 80618
2 CERTIFICATE OF DESIGNATION ex3-1.htm EX-3.1 115159
3 COMMON STOCK PURCHASE WARRANT ex4-1.htm EX-4.1 128024
4 SECURITIES PURCHASE AGREEMENT ex10-1.htm EX-10.1 240269
5 REGISTRATION RIGHTS AGREEMENT ex10-2.htm EX-10.2 175694
  Complete submission text file 0001387131-22-007475.txt   1069827

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE admp-20220630.xsd EX-101.SCH 2935
7 XBRL LABEL FILE admp-20220630_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE admp-20220630_pre.xml EX-101.PRE 22343
10 EXTRACTED XBRL INSTANCE DOCUMENT admp-8k_063022_htm.xml XML 3702
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36242 | Film No.: 221067330
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences